Missing/wrong data?
Log in to edit
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
scientific article published on 10 April 2021
Author/s
author: Catrin Plumpton, Rajiv Mohanraj, Girvan Burnside, John Paul Leach, Dyfrig A. Hughes, Anthony Marson
Work details
Publication date
April 10, 2021
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.